By contrast the frequencies of CCR6+IFNγ+ cells that can produce GM-CSF were significantly elevated in the CSF, as compared to the blood, although this was equally elevated in the OND and MS cohorts (Fig. 4B). This evidence concerns the gene CSF2 and myeloid sarcoma.